Clinical Trial Update: Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI [Phase 2]

View source ↗

Summary

Phase 2 trial assessing metformin for reducing colorectal cancer risk in individuals with a history of adenomas and elevated BMI; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomatous Polyp
• Colorectal Cancer
• Obesity

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenomatous Polyp, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-06-25